BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8878463)

  • 21. Identification of five novel germline mutations of the MEN1 gene in Japanese multiple endocrine neoplasia type 1 (MEN1) families.
    Sato M; Matsubara S; Miyauchi A; Ohye H; Imachi H; Murao K; Takahara J
    J Med Genet; 1998 Nov; 35(11):915-9. PubMed ID: 9832038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database.
    Giusti F; Cianferotti L; Boaretto F; Cetani F; Cioppi F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Fossi C; Giudici F; Gronchi G; Loli P; Mantero F; Marcocci C; Marini F; Masi L; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Sciortino G; Spada A; Tomassetti P; Tonelli F; Brandi ML
    Endocrine; 2017 Nov; 58(2):349-359. PubMed ID: 28132167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13.
    Stock JL; Warth MR; Teh BT; Coderre JA; Overdorf JH; Baumann G; Hintz RL; Hartman ML; Seizinger BR; Larsson C; Aronin N
    J Clin Endocrinol Metab; 1997 Feb; 82(2):486-92. PubMed ID: 9024241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation.
    Vierimaa O; Ebeling TM; Kytölä S; Bloigu R; Eloranta E; Salmi J; Korpi-Hyövälti E; Niskanen L; Orvola A; Elovaara E; Gynther A; Sane T; Välimäki M; Ignatius J; Leisti J; Salmela PI
    Eur J Endocrinol; 2007 Sep; 157(3):285-94. PubMed ID: 17766710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive diagnosis of multiple endocrine neoplasia (MEN 1) in four Australian kindreds.
    Grimmond SM; Teh BT; Hii SI; Cardinal J; Walters M; Epstein M; Edwards M; Hockey A; Pullan PT; Perry-Keene D; Boyages S; Cameron D; Hayward NK
    Aust N Z J Med; 1996 Feb; 26(1):27-32. PubMed ID: 8775525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
    van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families.
    Kopp I; Bartsch D; Wild A; Schilling T; Nies C; Bergenfelz A; Rieder H; Simon B; Rothmund M
    World J Surg; 2001 May; 25(5):610-6. PubMed ID: 11369988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple endocrine neoplasia 1: providing care for the family.
    Mahon SM; Waldman L
    Clin J Oncol Nurs; 2010 Oct; 14(5):657-60. PubMed ID: 20880824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
    Jap TS; Chiu CY; Won JG; Wu YC; Chen HS
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):336-42. PubMed ID: 15730416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
    Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
    J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of multiple endocrine neoplasia type 1 (MEN1) gene mutations on premature mortality in familial MEN1 syndrome with founder mutations.
    Ebeling T; Vierimaa O; Kytölä S; Leisti J; Salmela PI
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3392-6. PubMed ID: 15240620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
    Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
    Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Founder effect in multiple endocrine neoplasia type 1 (MEN 1) in Finland.
    Kytölä S; Villablanca A; Ebeling T; Nord B; Larsson C; Höög A; Wong FK; Välimäki M; Vierimaa O; Teh BT; Salmela PI; Leisti J
    J Med Genet; 2001 Mar; 38(3):185-9. PubMed ID: 11303512
    [No Abstract]   [Full Text] [Related]  

  • 39. [Multiple endocrine neoplasia type 1: genetic study of a large family].
    Orellana C; Palasí R; Martínez F; Ponce JL; Gil Sanz J; Sancho Fornos S; Prieto F
    Med Clin (Barc); 1999 Mar; 112(8):299-302. PubMed ID: 10207847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.